Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (217)	5/24/1999 4:54:00 PM
From: LLCF	Read Replies (1) \| Respond to of 555

I've got drug delivery conference on the calander today and tomorrow in Washington, and nothing else for quite a while.... I'll have to reload. DAK

To: LLCF who wrote (217)	5/24/1999 11:21:00 PM
From: LLCF	Read Replies (1) \| Respond to of 555

O.K. May expiration has come and gone... the two plays put on for "news" (CEPH Provigil sales, CORR integrelin sales) have expired... verdict is... Blah. Made good money on CEPH but because I leaned way long and was bullish.... the play to buy a "neutral" straddle was a loss of 2k on a 3k investment (rounding incl.commish), CORR straddle (neutral) was a gain of 1k on a 2k investment (w/commish). Clearly this news wasn't big enough to warrant the play. Notes on big moves shows that SCIOS would have been HUGE if I was on the ball... don't follow the stock, and didn't realize their destiny with Mr. FDA was so important to the company... on the other hand if the drug was approved and the stock went up 2-3$ it would have been a loser to buy the straddle... don't know where the stock would have opened with a positive outcome. THIS IS THE KIND OF THING WE'RE LOOKING FOR... (SCIOS). Anyway... I'll keep my eyes open, any ideas would be greatly appeciated... DAK